The International Cancer Genome Consortium have announced that 1,200 cancer whole genome sequences are now available via Amazon Web Services.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Thermo Fisher Scientific forms long-term partnership with Novartis and Pfizer to develop non-small cell cancer test to serve as companion diagnostic across drug development.
25 years since the Human Genome Project scientists have broken the $1000 genome and CRISPR gets a simplification upgrade.
Boston-based clinical screening company receives European seal of approval for breast and ovarian cancer test
This week FLG Content Manager, Liz Harley, considers the real and imaginary consequences of genomic apps. We’re prone to the occasional flight of fancy in the FLG office. I think it comes from working in field with such an exciting, and potentially terrifying future. This week, following the announcement that Illumina are giving consumer genomics the […]
Dean Schorno, former CFO of Adaptive Technologies Corp, joins 23andMe amid plans to relaunch health-focused products.